Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charmy Twala

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Computational Chemistry Advances in the Development of PARP1 Inhibitors for Breast Cancer TherapyCharmy Twala, Penny Govender, Krishna Govender
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Computational Evaluation of Novel PARP-1 Inhibitors for Breast Cancer: Docking, Molecular Dynamics, MM/GBSA, DFT and ADMET CalculationsCharmy Twala, Penny Govender, Ephraim Marondedze, et al.
Biomedicines|January 25, 2025
Ezetimibe Anticancer Activity via the p53/Mdm2 PathwayCharmy Twala, Sibusiso Malindisa, Chamone Munnik, et al.
Journal of Biomolecular Structure & Dynamics|November 29, 2024
Novel dihydrobenzofuran derivatives: design, synthesis, cytotoxic activity, apoptosis, molecular modelling and DNA binding studiesManish Rana, Imran Ansari, Charmy Twala, et al.
Journal of Biomolecular Structure & Dynamics|February 24, 2023
Synthesis, spectral characterization of pyrazole derived Schiff base analogs: molecular dynamic simulation, antibacterial and DNA binding studiesRazia Sultana, Asghar Ali, Charmy Twala, et al.
Journal of Biomolecular Structure & Dynamics|April 20, 2026
Exploring the binding energies of new pyrazoline derivatives to DNA/BSA: antifungal, antioxidant, MD simulations and TD-DFT studiesRabiya Mehandi, Charmy Twala, Saiema Ahmedi, et al.
Journal of Biomolecular Structure & Dynamics|January 31, 2025
1,3,4-oxadiazole derivatives: synthesis, characterization, antifungal activity, DNA binding investigations, TD-DFT calculations, and molecular modellingRabiya Mehandi, Charmy Twala, Saiema Ahmedi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Computational Chemistry Advances in the Development of PARP1 Inhibitors for Breast Cancer TherapyCharmy Twala, Penny Govender, Krishna Govender
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Computational Evaluation of Novel PARP-1 Inhibitors for Breast Cancer: Docking, Molecular Dynamics, MM/GBSA, DFT and ADMET CalculationsCharmy Twala, Penny Govender, Ephraim Marondedze, et al.
Biomedicines|January 25, 2025
Ezetimibe Anticancer Activity via the p53/Mdm2 PathwayCharmy Twala, Sibusiso Malindisa, Chamone Munnik, et al.
Journal of Biomolecular Structure & Dynamics|November 29, 2024
Novel dihydrobenzofuran derivatives: design, synthesis, cytotoxic activity, apoptosis, molecular modelling and DNA binding studiesManish Rana, Imran Ansari, Charmy Twala, et al.
Journal of Biomolecular Structure & Dynamics|February 24, 2023
Synthesis, spectral characterization of pyrazole derived Schiff base analogs: molecular dynamic simulation, antibacterial and DNA binding studiesRazia Sultana, Asghar Ali, Charmy Twala, et al.
Journal of Biomolecular Structure & Dynamics|April 20, 2026
Exploring the binding energies of new pyrazoline derivatives to DNA/BSA: antifungal, antioxidant, MD simulations and TD-DFT studiesRabiya Mehandi, Charmy Twala, Saiema Ahmedi, et al.
Journal of Biomolecular Structure & Dynamics|January 31, 2025
1,3,4-oxadiazole derivatives: synthesis, characterization, antifungal activity, DNA binding investigations, TD-DFT calculations, and molecular modellingRabiya Mehandi, Charmy Twala, Saiema Ahmedi, et al.
Pageof 1